Skip to main content
Equibles

GOLDMAN SACHS GROUP INC

Position in TMO — Thermo Fisher Scientific Inc.

CIK 886982 NEW YORK, NY
Back to TMO Full portfolio

Position in TMO

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$1,551,871,293
-$225,234,637 QoQ
Shares Held
3,157,226
+2.9% QoQ
Ownership
0.850%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 90.42431552255049.ToString("F0")% Shared 0.2937705441422312.ToString("F0")% None 9.281913933307278.ToString("F0")%

Common Shares in TMO Over Time

Shares Held

Position Value (USD)

Derivatives in TMO

reported options exposure · as of Mar 31, 2026
CallValue
$16,859,479
CallShares
34,300
PutValue
$36,618,985
PutShares
74,500

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Mar 31, 2026

GOLDMAN SACHS GROUP INC holds $5,861,764,434 across 35 Diagnostics & Research names. TMO ranks #1 (26.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TMO
Thermo Fisher Scientific Inc.
This page 		3,157,226 $1,551,871,293
2 DHR
Danaher Corp /De/
 4,609,288 $873,921,002
3 MTD
Mettler Toledo International Inc/
 387,844 $489,148,850
4 GH
Guardant Health, Inc.
 4,435,839 $409,738,446
5 A
Agilent Technologies, Inc.
 3,577,648 $407,780,316
6 IDXX
Idexx Laboratories Inc /De
 716,921 $402,830,739
7 DGX
Quest Diagnostics Inc
 1,348,694 $264,317,047
8 IQV
Iqvia Holdings Inc.
 1,177,280 $200,773,329

All Filings in TMO

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $36,618,985 74,500
2026-03-31 $16,859,479 34,300
2026-03-31 $1,551,871,293 3,157,226
2025-12-31 $1,777,105,930 3,066,884
2025-12-31 $30,247,290 52,200
2025-12-31 $58,524,450 101,000
2025-09-30 $9,166,878 18,900
2025-09-30 $1,258,993,573 2,595,756
2025-09-30 $242,510 500
2025-06-30 $1,054,196 2,600
2025-06-30 $851,466 2,100
2025-06-30 $941,270,927 2,321,489
2025-03-31 $1,202,259,817 2,416,117
2025-03-31 $497,600 1,000
2025-03-31 $1,244,000 2,500
2024-12-31 $1,146,266,975 2,203,385
2024-12-31 $2,861,265 5,500
2024-12-31 $2,341,035 4,500
2024-09-30 $1,523,477,906 2,462,903
2024-09-30 $2,783,565 4,500
2024-09-30 $8,969,265 14,500
2024-06-30 $1,330,765,744 2,406,448
2024-06-30 $3,318,000 6,000
2024-06-30 $3,318,000 6,000
2024-03-31 $7,032,641 12,100
2024-03-31 $7,207,004 12,400
2024-03-31 $1,137,214,082 1,956,632
2023-12-31 $16,879,122 31,800
2023-12-31 $1,032,001,193 1,944,274
2023-12-31 $17,675,307 33,300
2023-09-30 $11,591,293 22,900
2023-09-30 $1,101,362,140 2,175,874
2023-09-30 $10,275,251 20,300
2023-06-30 $1,086,138,972 2,081,723
2023-06-30 $5,687,075 10,900
2023-06-30 $5,530,550 10,600
2023-03-31 $17,579,285 30,500
2023-03-31 $17,752,196 30,800
2023-03-31 $1,106,026,938 1,918,953
2022-12-31 $30,343,019 55,100
2022-12-31 $1,065,236,562 1,934,367
2022-12-31 $76,545,910 139,000
2022-09-30 $25,765,252 50,800
2022-09-30 $1,192,684,163 2,351,553
2022-09-30 $13,947,725 27,500
2022-06-30 $1,058,458,840 1,948,275
2022-06-30 $19,666,736 36,200
2022-06-30 $9,181,432 16,900
2022-03-31 $16,715,395 28,300
2022-03-31 $14,529,990 24,600

Report a Problem

Category
Description
Email (optional, for follow-up)